Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Yichao Han is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for lung and esophageal cancers. His most impactful work includes the landmark RVlob randomized controlled trial (2024, 19 citations), which directly compared robotic-assisted lobectomy (RAL) with video-assisted lobectomy (VAL) for resectable non-small-cell lung cancer (NSCLC), providing crucial evidence that the two approaches yield comparable long-term survival and perioperative outcomes. Dr. Han has also been at the forefront of combined anatomic subsegmentectomy, demonstrating in a 2022 cohort study (8 citations) the early benefits of robotic-assisted thoracic surgery (RATS) over thoracoscopic methods for early-stage NSCLC. His contributions extend to esophageal cancer surgery, where he has refined intrathoracic esophagogastric anastomosis techniques, and to patient safety, advocating for surgical simulation to enhance proficiency in RATS. With a career dedicated to rigorous clinical trials and innovative surgical education, Dr. Han’s work directly shapes best practices in thoracic oncology, offering patients safer, more effective surgical options.